Lupin Diagnostics, a wholly owned subsidiary of global pharma major Lupin has achieved 100 per cent NABL (National Accreditation Board for Testing and Calibration Laboratories) accreditation across all its greenfield labs.
“The 27 greenfield labs across the country ensure timely and accurate reporting. Our goal is to empower doctors and patients with evidence-based diagnostics,” said Ravindra Kumar, CEO, Lupin Diagnostics.
This achievement highlights the adherence to quality control measures. The company aims to ensure that patients receive accurate and timely results while maintaining smooth operations.
